16/2/20, l'équipe de France [de rugby affrontant le Pays de Galles] à l'entrainement à Colombes : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 58014

Paul Cambon [ambassadeur de France à Londres] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 58120

Equipe du Pays de Galles [de rugby affrontant la France], Colombes, 17/2/20 : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 58042

Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial.

BACKGROUND: The true benefit of iron supplementation for nonanemic menstruating women with fatigue is unknown. We studied the effect of oral iron therapy on fatigue and quality of life, as well as on hemoglobin, ferritin and soluble transferrin receptor levels, in nonanemic iron-deficient women with unexplained fatigue. METHODS: We performed a multicentre, parallel, randomized controlled, closed-label, observer-blinded trial. We recruited from the practices of 44 primary care physicians in France from March to July 2006. We randomly assigned 198 women aged 18-53 years who complained of fatigue and who had a ferritin level of less than 50 ug/L and hemoglobin greater than 12.0 g/dL to receive either oral ferrous sulfate (80 mg of elemental iron daily; n = 102) or placebo (n = 96) for 12 weeks. The primary outcome was fatigue as measured on the Current and Past Psychological Scale. Biological markers were measured at 6 and 12 weeks. RESULTS: The mean score on the Current and Past Psychological Scale for fatigue decreased by 47.7% in the iron group and by 28.8% in the placebo group (difference -18.9%, 95% CI -34.5 to -3.2; p = 0.02), but there were no significant effects on quality of life (p = 0.2), depression (p = 0.97) or anxiety (p = 0.5). Compared with placebo, iron supplementation increased hemoglobin (0.32 g/dL; p = 0.002) and ferritin (11.4 μg/L; p < 0.001) and decreased soluble transferrin receptor (-0.54 mg/L; p < 0.001) at 12 weeks. INTERPRETATION: Iron supplementation should be considered for women with unexplained fatigue who have ferritin levels below 50 μg/L. We suggest assessing the efficiency using blood markers after six weeks of treatment. Trial registration no. EudraCT 2006-000478-56.

Report on the Special Investigation of the Nutrition Department of the Boone Community School District, For the Period August 30, 2004 through March 31, 2006 and Selected Activity for the period February 28, 2000 through March 31, 2006

Community School District Audit Report - Special Investigation

Parc des Princes, 1/1/20, rugby, match France-Écosse, M. Deschanel félicitant Struxiano [capitaine de l'équipe de France] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 57443

ABD e-News, March 5, 2004

March 5, 2004 e-news newsletter

Iowa Health Focus, March 2004

Monthly newsletter for Iowa Department of Public Health

ABD e-News March 12, 2004

ABD e-News

ABD e-News March 19, 2004

Weekly Newsletter